Construction of a Database for TMA

Status Recruiting

Clinical Trial Summary

Information about patients was collected by reviewing the Hitech case system and telephone and outpatient follow-up, and the case database was constructed by Epidata software. The sample size is expected to be 200 cases, the participating hospital is the First Affiliated Hospital of Soochow University, and the study time frame is from Dec 1, 2022, to Nov 31, 2027. The observation indexes of the study include the basic information of patients' age and gender and the clinical-related data of thrombotic microangiopathy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Thrombotic Microangiopathies

Clinical Trial Details

NCT number	NCT05634928
Study type	Observational [Patient Registry]
Source	The First Affiliated Hospital of Soochow University
Contact	Yue Han, PhD
Phone	+86 18913091817
Email	hanyue@suda.edu.cn
Status	Recruiting
Phase
Start date	December 1, 2022
Completion date	November 30, 2028

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04098445` - TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
Recruiting	`NCT03605511` - TTP and aHUS in Complicated Pregnancies
Not yet recruiting	`NCT05996679` - Automated Surveillance, Alert, and Rapid Diagnosis of Thrombotic Microangiopathies: the ASARD-TMA Study
Completed	`NCT02222545` - Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies	Phase 2
Recruiting	`NCT06102694` - Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy
Completed	`NCT03252925` - A Safety and Efficacy Study of NAC in Patients With TA-TMA	Phase 3
Recruiting	`NCT05855083` - Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA	Phase 2
Completed	`NCT03384693` - Defibrotide TMA Prophylaxis Pilot Trial	Phase 2
Not yet recruiting	`NCT05702996` - Multicenter, Uncontrolled Pilot Study Evaluating the Efficacy of Eculizumab in the Treatment of Gemcitabine-induced Thrombotic Microangiopathies	Phase 3
Not yet recruiting	`NCT02373267` - Screening of TMA Patients für ADAMTS13 Activity (Adamscreen)	N/A
Recruiting	`NCT06098378` - Study of Patients With Thrombotic Microangiopathy Associated With Mitomycin C, Treated or Not With Eculizumab
Completed	`NCT02134171` - Early Predictive Factors of Cardiac and Cerebral Involvement in TMA	N/A
Not yet recruiting	`NCT06182410` - Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma	Phase 2
Withdrawn	`NCT04970004` - Study in Adult and Pediatric Patients With HSCT-TMA
Recruiting	`NCT03205995` - Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome	Phase 3
Recruiting	`NCT04784455` - Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy	Phase 3
Active, not recruiting	`NCT04570397` - Ravulizumab and COVID-19	Phase 3
Completed	`NCT03518203` - Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients	Phase 2
Recruiting	`NCT04745195` - Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium
Recruiting	`NCT06291415` - The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)	Phase 1